1. Home
  2. NOTV vs OPXS Comparison

NOTV vs OPXS Comparison

Compare NOTV & OPXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • OPXS
  • Stock Information
  • Founded
  • NOTV 1974
  • OPXS 1987
  • Country
  • NOTV United States
  • OPXS United States
  • Employees
  • NOTV N/A
  • OPXS N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • OPXS Electronic Components
  • Sector
  • NOTV Health Care
  • OPXS Technology
  • Exchange
  • NOTV Nasdaq
  • OPXS Nasdaq
  • Market Cap
  • NOTV 62.5M
  • OPXS 72.2M
  • IPO Year
  • NOTV 1997
  • OPXS N/A
  • Fundamental
  • Price
  • NOTV $2.00
  • OPXS $11.45
  • Analyst Decision
  • NOTV Strong Buy
  • OPXS
  • Analyst Count
  • NOTV 1
  • OPXS 0
  • Target Price
  • NOTV $5.00
  • OPXS N/A
  • AVG Volume (30 Days)
  • NOTV 512.6K
  • OPXS 81.8K
  • Earning Date
  • NOTV 08-07-2025
  • OPXS 08-12-2025
  • Dividend Yield
  • NOTV N/A
  • OPXS N/A
  • EPS Growth
  • NOTV N/A
  • OPXS 36.84
  • EPS
  • NOTV N/A
  • OPXS 0.71
  • Revenue
  • NOTV $480,402,000.00
  • OPXS $37,431,000.00
  • Revenue This Year
  • NOTV $4.99
  • OPXS N/A
  • Revenue Next Year
  • NOTV $5.39
  • OPXS N/A
  • P/E Ratio
  • NOTV N/A
  • OPXS $17.02
  • Revenue Growth
  • NOTV N/A
  • OPXS 21.76
  • 52 Week Low
  • NOTV $1.15
  • OPXS $5.36
  • 52 Week High
  • NOTV $6.48
  • OPXS $13.00
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 49.04
  • OPXS 68.58
  • Support Level
  • NOTV $2.06
  • OPXS $10.03
  • Resistance Level
  • NOTV $2.30
  • OPXS $13.00
  • Average True Range (ATR)
  • NOTV 0.17
  • OPXS 0.80
  • MACD
  • NOTV 0.02
  • OPXS 0.08
  • Stochastic Oscillator
  • NOTV 70.31
  • OPXS 78.10

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About OPXS Optex Systems Holdings Inc.

Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, and light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson and Applied Optics Center Dallas and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor and others.

Share on Social Networks: